GSK plc Share Repurchase

GSK plc announced that on March 13, 2026, acting through its broker BNP Paribas SA, it purchased 445,000 of its own ordinary shares. The purchases were made at prices ranging from 2,027.00p to 2,060.00p, with a volume-weighted average price of 2,041.70p. These shares will be held as treasury shares. This transaction is part of the company's ongoing buyback program, which commenced on February 17, 2026. Since the program began, GSK has repurchased a total of 9,925,409 ordinary shares. Following this latest purchase, GSK will hold 249,816,503 ordinary shares in treasury, with 4,066,354,262 ordinary shares in issue.